Danaher Sign Up Information

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 4 filed on Jul 29, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=qvjB8RDrxpmjIjYtbWf0K9z61-TpdBQ_

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 4 filed on Jul 29, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=pVTJbpgsd5nfIj0LSywGZvfdvLbPgT8v

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Jul 29, 2019 (4:01pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Jul 29, 2019, at $142.68

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=sZJ7VgPv75lXIhV8Fuz1Qsn7H98RPn1X

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 4 filed on Jul 29, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=3UJMdzRyM5kUIn8RsqOOVyq3CN10AUfG

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 4 filed on Jul 29, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=ANgAKjRvRpnoIibAOjE3xy28iLCMpU_-

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 4 filed on Jul 29, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=jcFaXVd2fJnjIoPG9o531cSKgdKyAmEv

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 4 filed on Jul 29, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=GsxgzRyTZZnvIpoZMmNVz1ccjb6PdZdh

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 4 filed on Jul 29, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=BKvxueH2wJn5IjqpjtZ0xp1otRFGZWD2

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Aug 9, 2019 (4:04pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Aug 9, 2019, at $140.31

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=Fvqv36vFR5llIi9PiJCyQ25kpRRuhRhB

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Aug 5, 2019 (4:03pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Aug 5, 2019, at $135.70

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=q62YDuJpwZnKIiKndm146ppWkPiXIZDy

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Aug 8, 2019 (4:03pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Aug 8, 2019, at $140.89

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=G4jANqFR-JlsIh9-2-OaAyQe-qLbw0p3

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Aug 7, 2019 (4:02pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Aug 7, 2019, at $138.20

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=bWZhdvXr-JmrIo-023HTP9I8HK0xI4Cq

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Aug 6, 2019 (4:02pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Aug 6, 2019, at $138.23

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=7nWv7KTPp5n2Iv3okRW03uleCba0mGdT

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Jul 31, 2019 (4:04pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Jul 31, 2019, at $140.50

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=DqHVeZBz05njIgLiwtzjVuKDG7KpSUXs

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Aug 1, 2019 (4:01pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Aug 1, 2019, at $140.22

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=pTnBusnjJZm3InDIpdlKXiNLhmKzxTTG

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Aug 2, 2019 (4:04pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Aug 2, 2019, at $139.19

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=mErVFVPnZJkSIjX8NtdYwLrDOD569byS

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Jul 30, 2019 (4:01pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Jul 30, 2019, at $142.70

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=2dBmnKwET5myIsTFWpGrMKAJrdWmomwE

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Aug 12, 2019 (3:59pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Aug 12, 2019, at $138.44

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=YCuWrtXYzpnzIi0O1Z24dCBloK7mOHbz

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Aug 13, 2019 (4:02pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Aug 13, 2019, at $140.54

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=bVw2aVd3KpkUIpUMtGAbId2jfydilbsh

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Aug 14, 2019 (4:02pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Aug 14, 2019, at $136.36

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=rG3H6qtJN5nrInFAvTgNV7dWt0j_XxSa

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Aug 15, 2019 (4:01pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Aug 15, 2019, at $137.19

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=WG3kxcEkSJnTIrNe4RcdjXW3SVwD418H

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Aug 16, 2019 (4:03pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Aug 16, 2019, at $140.35

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=uAbxBaty6JkcIp27xAE6LRjBD_1Kb4dA

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Aug 20, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Aug 20, 2019, at $140.07

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=k4ja9jWvgpn2Ipl-QEyr9m7li0euOtf1

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Aug 19, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Aug 19, 2019, at $141.71

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=HEHM6ewKE5nqIufx6_ORg29qnXSvHKV9

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Aug 21, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Aug 21, 2019, at $140.32

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=Km8ZAHBbq5knIgPBWXElV8-R0PZ2gIP-

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 4 filed on Aug 21, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=buuwM3Nm8JklIjtZR8j4Fs9qD8jWSAJl

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Aug 22, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Aug 22, 2019, at $139.56

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=MCUNssyadJkZIuHrGITgSSkz71BjM7Qc

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 424B5 filed on Aug 23, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=n8Gub4Ng4pmDItT9_zaycEdFog2gbxOy

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Aug 23, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Aug 23, 2019, at $135.40

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=zazny3esipklIgcoaO42cjsOWlScDnOR

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 4 filed on Aug 26, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=29z4x4RE7JksIsD9rf7ylWAGqop3Bby_

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Aug 26, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Aug 26, 2019, at $136.40

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=f9dt4duR95kNIlUfp4m9oA76GIjsBR0S

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Aug 27, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Aug 27, 2019, at $138.25

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=GfYMaeYAepnVImAKvmqsoRGmUttmcfAU

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Aug 28, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Aug 28, 2019, at $139.49

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=pr8ncTVueplQIrBfjWsro_L2_R25QTTs

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 8-K filed on Aug 29, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=rqR83TpGUpkuImitJXzRCfZ3yz_VdnNa

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Aug 29, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Aug 29, 2019, at $141.68

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=CaCWvr3MVZmMIubwxu8wjjP8yPBAjzBq

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Aug 30, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Aug 30, 2019, at $142.09

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=fCMdUh4PuZkUIleUYTDP73Qrv2OaDTGP

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form FWP filed on Sep 3, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=eJa9d6GB4ZkUIuQ7NuT3NgXthHrOZUh_

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Sep 3, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Sep 3, 2019, at $139.87

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=YJZFKgGzqZkJIuuHQi3CshtLXWcs-jo2

News Release Issued: Sep 3, 2019 (9:10pm EDT)

To view this release online and get more information about Danaher Corporation: IR Room visit: http://investors.danaher.com/2019-09-03-Danaher-Announces-Pricing-Of-Euro-Denominated-Senior-Notes-Offering

Danaher Announces Pricing Of Euro-Denominated Senior Notes Offering

WASHINGTON, Sept. 3, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today that its wholly-owned subsidiary, DH Europe Finance II S.à r.l. ("Danaher International II"), has priced an offering of:

• €1,250,000,000 principal amount of 0.200% senior notes due 2026 at an offering price of 99.833% of the principal amount;
• €1,250,000,000 principal amount of 0.450% senior notes due 2028 at an offering price of 99.751% of the principal amount;
• €1,750,000,000 principal amount of 0.750% senior notes due 2031 at an offering price of 99.920% of the principal amount;
• €1,250,000,000 principal amount of 1.350% senior notes due 2039 at an offering price of 99.461% of the principal amount; and
• €750,000,000 principal amount of 1.800% senior notes due 2049 at an offering price of 99.564% of the principal amount (collectively, the "senior notes").

Danaher estimates that the net proceeds from the sale of the senior notes in this offering will be approximately €6.197 billion, after deducting the underwriting discounts and estimated offering expenses payable by Danaher. Danaher anticipates using the net proceeds to fund a portion of the cash consideration payable for, and certain costs associated with, its acquisition of the Biopharma Business of GE Life Sciences (the "GE Biopharma Acquisition"). Pending completion of the GE Biopharma Acquisition, Danaher may invest the net proceeds of the offering in short-term bank deposits or invest them in interest-bearing, investment-grade securities. The senior notes will be fully and unconditionally guaranteed on a senior unsecured basis by Danaher. The offering is expected to close on September 18, 2019, subject to customary closing conditions.

The offering is being made pursuant to an effective shelf registration statement on file with the U.S. Securities and Exchange Commission.

The offering of senior notes may be made only by means of a prospectus and prospectus supplement.  A copy of the prospectus and prospectus supplement relating to the securities can be obtained from Barclays Bank PLC at Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, Phone: 1-888-603-5847; BNP Paribas at 10 Harewood Avenue, London NW1 6AA, United Kingdom, Attention: Fixed Income Syndicate, Phone: 1-800-854-5674; Citigroup Global Markets Limited c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, by calling 1 (800) 831-9146 or by email at prospectus@citi.com; Deutsche Bank AG, London Branch at Winchester House, 1 Great Winchester Street, London EC2N 2DB, Attention: Syndicate Desk, Phone: +44-20-7545-4361, Fax: +44-20-7545-4455; or Banco Santander, S.A., Ciudad Grupo Santander, Avenida de Cantabria s/n, Boadilla del Monte, Madrid, Spain, Attention: Syndicate Desk, Phone: +34-91-257-2029 or +44-20-7756-6802.

This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, the senior notes or any other securities, nor shall there be any offer, solicitation or sale of any security mentioned in this press release in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

ABOUT DANAHER

Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher's globally diverse team of approximately 71,000 associates is united by a common culture and operating system, the Danaher Business System, and its Shared Purpose, Helping Realize Life's Potential.

FORWARD-LOOKING STATEMENTS

Statements in this release that are not strictly historical, including the statements regarding the offering of the senior notes, the anticipated use of proceeds and any other statements regarding events or developments that we believe or anticipate will or may occur in the future, may be "forward-looking statements" within the meaning of the federal securities laws. There are a number of important factors that could cause actual events to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking statements. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in Danaher's SEC filings, including Danaher's 2018 Annual Report on Form 10-K and Danaher's Quarterly Reports on Form 10-Q for the first and second quarters of 2019. These forward-looking statements speak only as of the date of this release and Danaher and Danaher International II do not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.

SOURCE Danaher Corporation

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=VE7CMBtTA5nxIu0fCeLjSbgkGECG-uNf

News Release Issued: Sep 4, 2019 (7:14am EDT)

To view this release online and get more information about Danaher Corporation: IR Room visit: http://investors.danaher.com/2019-09-04-Envista-Announces-Launch-of-IPO-Roadshow

Envista Announces Launch of IPO Roadshow

BREA, Calif., Sept. 4, 2019 /PRNewswire/ -- Envista Holdings Corporation, a subsidiary of Danaher Corporation (NYSE: DHR), today announced it has launched a roadshow for the initial public offering (IPO) of its common stock.

Envista is offering 26,768,000 shares of its common stock in the IPO. The underwriters will also have a 30-day option to purchase up to 4,015,200 additional shares of common stock at the IPO price, less underwriting discounts and commissions.  The IPO price is currently expected to be between $21.00 and $24.00 per share. Envista expects to list its common stock on the New York Stock Exchange under the ticker symbol "NVST."

Following the IPO, Danaher is expected to hold approximately 82.7% of Envista (80.6% if the underwriters' overallotment option is exercised in full). The net proceeds from the IPO are expected to be paid to Danaher as partial consideration for the dental businesses that Danaher is transferring to Envista in connection with the IPO.

J.P. Morgan, Goldman Sachs & Co. LLC and Morgan Stanley are joint lead book-running managers for the offering. Baird, Evercore ISI and Jefferies are book-running managers for the offering. BofA Merrill Lynch, Credit Suisse, Stifel and William Blair are co-managers for the offering.

The offering will be made only by means of a prospectus. Copies of the preliminary prospectus related to the offering may be obtained from:

J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by telephone at 1-866-803-9204 or by email at prospectus-eq_fi@jpmchase.com;

Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282, email: prospectus-ny@ny.email.gs.com, telephone: 1-866-471-2526, fax: 1-212-902-9316; or

Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, Second Floor, New York, New York 10014.

A registration statement relating to these securities was filed with the U.S. Securities and Exchange Commission (SEC) but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

ABOUT ENVISTA

Envista is a global dental products company that develops and provides a comprehensive portfolio of dental consumables, equipment and services to dental professionals covering an estimated 90% of dentists' clinical needs for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile. Envista's operating companies, Nobel Biocare Systems, Ormco and KaVo Kerr, serve more than one million dentists in over 150 countries.

ABOUT DANAHER

Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher's globally diverse team of approximately 71,000 associates is united by a common culture and operating system, the Danaher Business System, and its Shared Purpose, Helping Realize Life's Potential.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements that are based on management's current expectations, but actual results may differ materially due to various factors. These statements relate to the offering and the use of proceeds therefrom. There are significant risks and uncertainties relating to the offering. There can be no guarantees that the IPO will be consummated on the timeline anticipated or at all or that Danaher will achieve the anticipated benefits of the IPO. Danaher's ability to consummate and achieve the anticipated benefits of the IPO may be materially affected by such factors as changes to the business, results of operation or financial condition of Envista or Danaher, changes in the dental products industry, adverse market or macroeconomic conditions and other factors outside Danaher's control that could affect the advisability, pricing and timing of the potential IPO.  Each of Danaher and Envista undertakes no duty to update forward-looking statements, except as may be required by law.

SOURCE Danaher Corporation; Envista Holdings Corporation

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=dKTkcATqH5nBIhjqnA4_p2JOHv1wVuHd

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Sep 4, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Sep 4, 2019, at $140.26

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=AKruDNwpSpkUIoKt7oyo3Nm6eX5yeC4-

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 8-K filed on Sep 5, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=XwDtWwGRwZnpIv1OXl367AvUYsQT2Z3C

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 424B5 filed on Sep 5, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=zmRMtXkTGJmQIshdgMmXiiS_0zPFtnVY

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Sep 6, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Sep 6, 2019, at $144.33

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=huX23GUGG5lWIqsjKg5p_I0zGM7TawKr

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Sep 10, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Sep 10, 2019, at $136.59

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=vc7pDEyq0ZmIIg0ZXPRErteTD4CpTJqz

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form CERT filed on Sep 18, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=u3cnHhevfJn-In2rCRDMU-AzbQfj5Li6

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 3 filed on Sep 17, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=TbErnzE8YplvIsGlkeC4zFR2Pqt50z_H

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 4 filed on Sep 10, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=ZX3FwTnEIpndIiENAJaY1wsEyVTonJQN

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Sep 13, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Sep 13, 2019, at $141.02

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=yVNERk23yZmGIthAkuwbw_1eDYi0J01e

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Sep 12, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Sep 12, 2019, at $141.74

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=B9FBqC4usJkeInInjCUIIpjH8t_dOLA-

News Release Issued: Sep 9, 2019 (4:35pm EDT)

To view this release online and get more information about Danaher Corporation: IR Room visit: http://investors.danaher.com/2019-09-09-Danaher-To-Webcast-Water-Quality-Platform-Investor-And-Analyst-Meeting-At-Hach

Danaher To Webcast Water Quality Platform Investor And Analyst Meeting At Hach

WASHINGTON, Sept. 9, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) will host a live video webcast of its Water Quality Platform Investor and Analyst Meeting at Hach on September 17, 2019 beginning at 8:00 a.m. MT. The event will be held at Danaher's Hach facility in Loveland, Colorado and hosted by Joakim Weidemanis, Executive Vice President of the Water Quality and Product Identification platforms, and Matt McGrew, Executive Vice President and Chief Financial Officer. A link to the webcast and accompanying slide presentation will be available on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations." A replay of the video webcast will be available following the presentation. 

ABOUT DANAHER
Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher's globally diverse team of approximately 71,000 associates is united by a common culture and operating system, the Danaher Business System, and our Shared Purpose, Helping Realize Life's Potential. For more information, please visit www.danaher.com.

SOURCE Danaher Corporation

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=TJKh6zMx8Jl6ImUoawhfaEEuKQkzmv9m

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Sep 17, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Sep 17, 2019, at $142.33

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=g3BKhYvHKJl2IoA9Q7NG0NuuQQhgjMhs

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Sep 5, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Sep 5, 2019, at $142.95

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=Ad72WjsTEJnaIm4p8QRoObQ2j-kLQlqA

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 8-A12B filed on Sep 18, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=bH4VtGGHPJl6IqkmHtJyHWzDnbQM8JWZ

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Sep 18, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Sep 18, 2019, at $143.95

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=xqkV36G9W5neIpxu063KSyCl6bM1MH6E

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Sep 11, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Sep 11, 2019, at $139.50

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=yzDvB8zwmZnRIk_0MRml3qgkhq0P3pmd

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Sep 9, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Sep 9, 2019, at $139.36

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=G838qYuaIJmiIifBxSFkdNJjzN5eJ2tS

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 8-K filed on Sep 18, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=vaJJtfK2IJkhIvRjpHGwLpgobGh77BNo

News Release Issued: Sep 10, 2019 (4:15pm EDT)

To view this release online and get more information about Danaher Corporation: IR Room visit: http://investors.danaher.com/2019-09-10-Danaher-Announces-Quarterly-Dividend

Danaher Announces Quarterly Dividend

WASHINGTON, Sept. 10, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.17 per share of its common stock, payable on October 25, 2019 to holders of record on September 27, 2019. In addition, Danaher announced today that its Board of Directors has approved a quarterly cash dividend of $11.875 per share of its 4.75% Series A Mandatory Convertible Preferred Stock, payable on October 15, 2019 to holders of record on September 30, 2019.

ABOUT DANAHER
Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher's globally diverse team of approximately 71,000 associates is united by a common culture and operating system, the Danaher Business System, and its Shared Purpose, Helping Realize Life's Potential. For more information, please visit www.danaher.com.  

SOURCE Danaher Corporation

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=vZmvhZ4J-JkuIjnsSdeehC-d6Dx1nh_o

News Release Issued: Sep 17, 2019 (7:51pm EDT)

To view this release online and get more information about Danaher Corporation: IR Room visit: http://investors.danaher.com/2019-09-17-Envista-Announces-Pricing-of-Initial-Public-Offering

Envista Announces Pricing of Initial Public Offering

BREA, Calif., Sept. 17, 2019 /PRNewswire/ -- Envista Holdings Corporation, a subsidiary of Danaher Corporation (NYSE: DHR), announced today the pricing of its initial public offering (IPO) of 26,768,000 shares of its common stock at a price to the public of $22.00 per share. The shares are expected to begin trading on the New York Stock Exchange under the ticker symbol "NVST." The gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be $588,896,000, excluding any exercise of the underwriters' option to purchase additional shares. The offering is expected to close on September 20, 2019, subject to customary closing conditions.

Envista has granted the underwriters a 30-day option to purchase up to 4,015,200 additional shares of common stock at the initial price to the public, less underwriting discounts and commissions.

Following the IPO, Danaher is expected to hold approximately 82.7% of Envista (80.6% if the underwriters' overallotment option is exercised in full). The net proceeds from the IPO are expected to be paid to Danaher as partial consideration for the dental businesses that Danaher is transferring to Envista in connection with the IPO.

J.P. Morgan, Goldman Sachs & Co. LLC and Morgan Stanley are joint lead book-running managers for the offering. Baird, Evercore ISI and Jefferies are book-running managers for the offering. BofA Merrill Lynch, Credit Suisse, Stifel and William Blair are co-managers for the offering.

The offering will be made only by means of a prospectus. Copies of the prospectus related to the offering may be obtained from:

J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by telephone at 866-803-9204 or by email at prospectus-eq_fi@jpmchase.com;

Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282, email: prospectus-ny@ny.email.gs.com, telephone: 1-866-471-2526, fax: 1-212-902-9316; or

Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, Second Floor, New York, New York 10014.

A registration statement relating to these securities was filed with, and declared effective by, the U.S. Securities and Exchange Commission (SEC). This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

ABOUT ENVISTA

Envista is a global dental products company that develops and provides a comprehensive portfolio of dental consumables, equipment and services to dental professionals covering an estimated 90% of dentists' clinical needs for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile. Envista's operating companies, Nobel Biocare Systems, Ormco and KaVo Kerr, serve more than one million dentists in over 150 countries.

ABOUT DANAHER

Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher's globally diverse team of approximately 71,000 associates is united by a common culture and operating system, the Danaher Business System, and its Shared Purpose, Helping Realize Life's Potential.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements that are based on management's current expectations, but actual results may differ materially due to various factors. These statements relate to the offering and the use of proceeds therefrom. There are significant risks and uncertainties relating to the offering. There can be no guarantees that the IPO will be consummated on the timeline anticipated or at all or that Danaher will achieve the anticipated benefits of the IPO. Danaher's ability to consummate and achieve the anticipated benefits of the IPO may be materially affected by such factors as changes to the business, results of operation or financial condition of Envista or Danaher, changes in the dental products industry, adverse market or macroeconomic conditions and other factors outside Danaher's control.  Each of Danaher and Envista undertakes no duty to update forward-looking statements, except as may be required by law.

SOURCE Danaher Corporation; Envista Holdings Corporation

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=B97pzCBn25n5Imou3ods4uZky8sCgA4E

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Sep 16, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Sep 16, 2019, at $140.65

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=U8fjXwDc-pkdIq9C0OvQAn0rqhVmA911

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Sep 19, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Sep 19, 2019, at $145.75

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=BNwFUpRDSplhIphU6-7BNps4hgGceEeN

News Release Issued: Sep 20, 2019 (4:15pm EDT)

To view this release online and get more information about Danaher Corporation: IR Room visit: http://investors.danaher.com/2019-09-20-Envista-Announces-IPO-Closing

Envista Announces IPO Closing

BREA, Calif., Sept. 20, 2019 /PRNewswire/ -- Envista Holdings Corporation, a subsidiary of Danaher Corporation (NYSE: DHR), today announced the closing of its previously announced initial public offering (IPO) of 26,768,000 shares of its common stock at a price to the public of $22.00 per share. In connection with the IPO, the underwriters exercised in full their option to purchase an additional 4,015,200 shares of common stock at the price to the public less underwriting discounts, bringing the total IPO size to 30,783,200 shares. The shares began trading on the New York Stock Exchange on September 18, 2019 under the ticker symbol "NVST." 

As of the closing of the IPO, Danaher holds approximately 80.6% of Envista.

After deducting underwriting discounts and commissions payable by Envista, the net proceeds to Envista were approximately $643.4 million. The net proceeds from the IPO have been paid to Danaher as partial consideration for the dental businesses that Danaher transferred to Envista in connection with the IPO.

J.P. Morgan, Goldman Sachs & Co. LLC and Morgan Stanley acted as joint lead book-running managers for the offering. Baird, Evercore ISI and Jefferies acted as book-running managers for the offering. BofA Merrill Lynch, Credit Suisse, Stifel and William Blair acted as co-managers for the offering.

The offering was made only by means of a prospectus. Copies of the prospectus related to the offering may be obtained from:

J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by telephone at 866-803-9204 or by email at prospectus-eq_fi@jpmchase.com;

Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282, email: prospectus-ny@ny.email.gs.com, telephone: 1-866-471-2526, fax: 1-212-902-9316; or

Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, Second Floor, New York, New York 10014.

A registration statement relating to these securities was filed with, and declared effective by, the U.S. Securities and Exchange Commission (SEC). This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

ABOUT ENVISTA

Envista is a global dental products company that develops and provides a comprehensive portfolio of dental consumables, equipment and services to dental professionals covering an estimated 90% of dentists' clinical needs for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile. Envista's operating companies, Nobel Biocare Systems, Ormco and KaVo Kerr, serve more than one million dentists in over 150 countries.

ABOUT DANAHER

Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher's globally diverse team of approximately 71,000 associates is united by a common culture and operating system, the Danaher Business System, and its Shared Purpose, Helping Realize Life's Potential.

SOURCE Danaher Corporation; Envista Holdings Corporation

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=e99fCtgUdJlSIvBilWTELuW2m5H9JsTD

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Sep 20, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Sep 20, 2019, at $146.47

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=TXCn4PM8QZnaIngCg9AG-IW0o8G_7GyG

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 8-K filed on Sep 20, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=VfTW49g68JmxIjDmh5lFGkbrEhqY3sEn

News Release Issued: Sep 23, 2019 (4:27pm EDT)

To view this release online and get more information about Danaher Corporation: IR Room visit: http://investors.danaher.com/2019-09-23-Danaher-Announces-Redemption-Of-Senior-Notes

Danaher Announces Redemption Of Senior Notes

WASHINGTON, Sept. 23, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it will redeem all of its $500,000,000 aggregate principal amount of 2.400% Senior Notes due 2020 (the "Danaher 2020 Notes") and all of the $375,000,000 aggregate principal amount of 5.00% Senior Notes due 2020 originally issued by Pall Corporation and subsequently guaranteed by Danaher (the "Pall 2020 Notes" and together with the Danaher 2020 Notes, the "Notes"), in each case at a redemption price equal to the outstanding principal amount and a make-whole premium as specified in the applicable indenture, plus accrued and unpaid interest.  The redemption date for the Notes will be October 24, 2019. Danaher intends to fund the redemption using a portion of the cash distribution it received in connection with the initial public offering of Envista Holdings Corporation, Danaher's Dental business.

ABOUT DANAHER

Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher's globally diverse team of approximately 71,000 associates is united by a common culture and operating system, the Danaher Business System, and its Shared Purpose, Helping Realize Life's Potential.

SOURCE Danaher Corporation

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=ZKcyAXYnspm7Ii0w6xFYDhpATm30m_LT

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Sep 23, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Sep 23, 2019, at $144.60

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=Zp3kkbygwZkrIvukibBubD3y5M4KmXjO

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Sep 24, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Sep 24, 2019, at $144.55

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=kRmeeJz4O5k8Io4Ykn7JZzw31QLeTI6f

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Sep 25, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Sep 25, 2019, at $143.95

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=KEag2mdsvJlsItX9MXR1w4xhHRg7gm9n

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Sep 27, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Sep 27, 2019, at $141.56

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=q9w7ftBX5JkXIqzEA-lCD0OJHHcnN8n4

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Sep 26, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Sep 26, 2019, at $142.76

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=pHpBRkTKqpl_IgiXgjoE0K3gYBEAcJdf

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Oct 1, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Oct 1, 2019, at $141.92

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=yNC9WwAsn5lUIghYcNxCwLgMfO5klxJG

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Sep 30, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Sep 30, 2019, at $144.43

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=GyRXNn3BM5m6IkIoH8NVCT8rkPykqBd3

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Oct 4, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Oct 4, 2019, at $141.65

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=ygAKHhwT8pkjIjbt0HLeL53mEfo6NDRs

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Oct 7, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Oct 7, 2019, at $139.68

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=xxW3dAPv05mbIkkhTY91e_mzIB68ANeO

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Oct 2, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Oct 2, 2019, at $137.11

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=MaxJmqkVzpkIImSJcJ_fOsVBe4Z_V5rI

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Oct 3, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Oct 3, 2019, at $138.81

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=Eznvcy9avZlIIkUDrKAPg_5b2RlmsyHC

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Oct 8, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Oct 8, 2019, at $135.62

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=Zw3kT73fLJmEIr7UZX0wD98lFykpFxkv

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Oct 9, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Oct 9, 2019, at $137.20

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=rUvu8EFqcpkcIs8Zt1D2UtzT9-jZB8VM

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Oct 10, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Oct 10, 2019, at $138.76

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=juuuwbrrQ5lMIowuOpO8D6YWxF07NSXw

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Oct 11, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Oct 11, 2019, at $138.72

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=GDvYxvUCVpnHIhMGtxDkkPDNB2FaE3RU

News Release Issued: Oct 9, 2019 (4:15pm EDT)

To view this release online and get more information about Danaher Corporation: IR Room visit: http://investors.danaher.com/2019-10-09-Danaher-Schedules-Third-Quarter-2019-Earnings-Conference-Call

Danaher Schedules Third Quarter 2019 Earnings Conference Call

WASHINGTON, Oct. 9, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the third quarter 2019 on Thursday, October 24, 2019 beginning at 8:00 a.m. ET and lasting approximately 1 hour.

The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations." A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available until the next quarterly earnings call.

You can access the conference call by dialing 866-503-8675 within the U.S. or +1 786-815-8792 outside the U.S. a few minutes before 8:00 a.m. ET and notifying the operator that you are dialing in for Danaher's earnings conference call (access code 6177645). A replay of the conference call will be available shortly after the conclusion of the call until October 31, 2019. You can access the replay dial-in information on the "Investors" section of Danaher's website under the subheading "Events & Presentations."

Danaher's earnings press release, the webcast slides and other related presentation materials will be posted to the "Investors" section of Danaher's website under the subheading "Quarterly Earnings" beginning at 6:00 a.m. ET on the date of the earnings call and will remain available following the call.

ABOUT DANAHER
Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher's globally diverse team of approximately 71,000 associates is united by a common culture and operating system, the Danaher Business System, and its Shared Purpose, Helping Realize Life's Potential. For more information, please visit www.danaher.com.

SOURCE Danaher Corporation

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=VuVMkN6P0Zk-IodCttBR5BbI1b6NoIUD

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Oct 14, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Oct 14, 2019, at $138.80

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=Fed3AfaJ45mFIuupC8S690YhYE1PPuFc

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Oct 15, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Oct 15, 2019, at $137.59

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=fqPBNvw9WZnKIrENAeeXQtVREMYAFCd-

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Oct 16, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Oct 16, 2019, at $137.39

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=hYhD9GHh4plAIic9O_kHbO2vpW4wrFTu

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Oct 17, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Oct 17, 2019, at $137.77

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=2EbxRKtcM5mgIpvlJe-WwOsjJbw-5Srd

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Oct 18, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Oct 18, 2019, at $138.01

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=jmutayBXhJnIIl6GgCM9KFuBqAaDyZiF

News Release Issued: Oct 21, 2019 (1:00am EDT)

To view this release online and get more information about Danaher Corporation: IR Room visit: http://investors.danaher.com/2019-10-21-Danaher-Reaches-Agreement-To-Sell-Certain-Businesses-To-Sartorius-AG-As-Part-Of-The-GE-Biopharma-Acquisition-Regulatory-Process

Danaher Reaches Agreement To Sell Certain Businesses To Sartorius AG As Part Of The GE Biopharma Acquisition Regulatory Process

WASHINGTON, Oct. 21, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced that it has signed an agreement to sell its label-free biomolecular characterization, chromatography hardware and resins, and microcarriers and particle validation standards businesses to Sartorius AG for approximately $750 million. The combined revenue of the businesses, which are part of Danaher's Life Sciences segment, was approximately $140 million in 2018.

Danaher entered into the agreement to sell these businesses as a step towards obtaining regulatory approval for its pending acquisition of the GE Biopharma business, and the closing of the Sartorius AG agreement is conditioned upon Danaher's closing its acquisition of the GE Biopharma business. Danaher's acquisition of the GE Biopharma business, the proposed regulatory remedies (the package of businesses being sold), the approval of Sartorius as the buyer in such remedies, and Sartorius' acquisition described above all remain subject to approvals from various regulatory authorities.

Thomas P. Joyce, Jr., President and Chief Executive Officer, stated, "This represents a significant step in the regulatory process toward closing the GE Biopharma acquisition. While timing around meeting all closing conditions, including regulatory approvals, is still uncertain, we remain very encouraged by the progress to date and expect closing of the transaction in the first quarter of 2020."

ABOUT DANAHER

Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher's globally diverse team of approximately 71,000 associates is united by a common culture and operating system, the Danaher Business System, and its Shared Purpose, Helping Realize Life's Potential. For more information, please visit www.danaher.com.

FORWARD-LOOKING STATEMENTS

Statements in this release that are not strictly historical, including statements regarding the proposed sale of the product lines identified above, the acquisition of GE Biopharma, the expected timetable for completing the acquisition of GE Biopharma, anticipated regulatory approvals relating to the acquisition of GE Biopharma and any other statements regarding events or developments that we believe or anticipate will or may occur in the future, are "forward-looking" statements within the meaning of the U.S. federal securities laws. There are a number of important factors that could cause actual results, developments and business decisions to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking statements. These factors include, among other things, general economic conditions and conditions affecting the industries in which Danaher and GE Biopharma operate; the uncertainty of regulatory approvals and the timing or conditionality thereof; the parties' ability to satisfy the acquisition agreement conditions and consummate the transaction on the anticipated timetable or at all; Danaher's ability to successfully integrate GE Biopharma's operations and employees with Danaher's existing business; and GE Biopharma's performance and maintenance of important business relationships. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in our SEC filings, including our 2018 Annual Report on Form 10-K and Quarterly Reports on Form 10-Q for the first quarter of 2019 and second quarter of 2019. These forward-looking statements speak only as of the date of this release and except to the extent required by applicable law, the Company does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.

These factors include, among other things, the uncertainty of regulatory approvals with respect to the GE Biopharma acquisition and the timing or conditionality thereof, the parties' ability to satisfy the acquisition agreement conditions and consummate the acquisition of GE Biopharma on the anticipated timetable and terms or at all, Danaher's ability to successfully integrate GE Biopharma's operations and employees with Danaher's existing business, the ability to realize anticipated financial, tax and operational synergies and benefits, GE Biopharma's performance and maintenance of important business relationships.

SOURCE Danaher Corporation

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=yEefwmWPypk3Iq5tGDBBzvzZPWBtfYxD

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Oct 21, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Oct 21, 2019, at $138.23

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=uRq7BeG6jJl6IuCfW7GssKyIRc1ubws6

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Oct 22, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Oct 22, 2019, at $137.08

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=mxm2wAPHUJn6Ih-o-Xn4sIOSGCe-3fIU

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Oct 23, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Oct 23, 2019, at $138.45

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=2kUHgHtzEZlMIgW-dUc2fbTdPEARgCuk

News Release Issued: Oct 24, 2019 (6:00am EDT)

To view this release online and get more information about Danaher Corporation: IR Room visit: http://investors.danaher.com/2019-10-24-Danaher-Reports-Third-Quarter-2019-Results

Danaher Reports Third Quarter 2019 Results

WASHINGTON, Oct. 24, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the third quarter 2019. For the quarter ended September 27, 2019, net earnings attributable to Danaher common stockholders were $648.4 million, or $0.89 per diluted share which represents a 4.5% year-over-year decrease from the comparable 2018 period.

Non-GAAP adjusted diluted net earnings per share for the third quarter 2019 were $1.16 which represents a 5.5% increase over the comparable 2018 period. For the third quarter 2019, revenues increased 4.0% year-over-year to $5.0 billion, with non-GAAP core revenue growth of 5.0%. Excluding our Dental segment, now named Envista (NYSE: NVST), non-GAAP core revenue growth for the third quarter 2019 was 6.0%.

For the fourth quarter 2019, the Company anticipates that diluted net earnings per share will be in the range of $1.06 to $1.09 and non-GAAP adjusted diluted net earnings per share will be in the range of $1.32 to $1.35.

For the full year 2019, the Company now anticipates that diluted net earnings per share will be in the range of $3.38 to $3.41 versus previous guidance of $3.38 to $3.43. The Company now expects 2019 non-GAAP adjusted diluted net earnings per share to be $4.74 to $4.77. Both GAAP and non-GAAP earnings per share figures include the dilution from the 19.4% non-controlling interest of Envista the Company no longer owns.

Thomas P. Joyce, Jr., President and Chief Executive Officer, stated, "We are pleased by our strong third quarter performance as we delivered another quarter of 5% core revenue growth and solid margin expansion. We believe our ongoing investments in innovation and commercial initiatives helped to continue building sustainable competitive advantages across a number of our businesses."

"During the quarter we also made meaningful progress on our two most recent portfolio moves. On September 18^th, our Dental business, now called Envista, started trading as a public company. I want to thank Amir Aghdaei and all the Envista associates for their contributions. We wish them the very best as they embark on this exciting new endeavor," Joyce added. "We also achieved several important milestones related to the GE Biopharma acquisition. Earlier this week, we announced the planned sale of certain businesses to Sartorius in connection with the regulatory approval process. In addition, we raised approximately $6.8 billion in euro-denominated debt in September to be used to fund the acquisition."

Joyce concluded, "We remain encouraged by our performance and are excited about the opportunities ahead. We believe our differentiated portfolio and the power of the Danaher Business System position us well through the end of 2019 and beyond."

Danaher will discuss its results during its quarterly investor conference call today starting at 8:00 a.m. ET. The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations." A replay of the webcast will be available in the same section of Danaher's website shortly after the conclusion of the presentation and will remain available until the next quarterly earnings call.

The conference call can be accessed by dialing 866-503-8675 within the U.S. or by dialing +1 786-815-8792 outside the U.S. a few minutes before the 8:00 a.m. ET start and telling the operator that you are dialing in for Danaher's investor conference call (access code 6177645). A replay of the conference call will be available shortly after the conclusion of the call and until October 31, 2019. You can access the replay dial-in information on the "Investors" section of Danaher's website under the subheading "Events & Presentations." In addition, presentation materials relating to Danaher's results have been posted to the "Investors" section of Danaher's website under the subheading "Quarterly Earnings."

ABOUT DANAHER

Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher's globally diverse team of approximately 71,000 associates is united by a common culture and operating system, the Danaher Business System, and its Shared Purpose, Helping Realize Life's Potential. For more information, please visit www.danaher.com.

NON-GAAP MEASURES

In addition to the financial measures prepared in accordance with generally accepted accounting principles (GAAP), this earnings release also contains non-GAAP financial measures. Calculations of these measures, the reasons why we believe these measures provide useful information to investors, a reconciliation of these measures to the most directly comparable GAAP measures and other information relating to these non-GAAP measures are included in the supplemental reconciliation schedule attached.

FORWARD-LOOKING STATEMENTS

Statements in this release that are not strictly historical, including the statements regarding the Company's anticipated financial performance for the fourth quarter and full year 2019 and opportunities and positioning for 2019 and beyond, the anticipated acquisition of GE Biopharma, the regulatory approval process related thereto and any other statements regarding events or developments that we believe or anticipate will or may occur in the future are "forward-looking" statements within the meaning of the federal securities laws. There are a number of important factors that could cause actual results, developments and business decisions to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking statements. These factors include, among other things, the uncertainty of regulatory approvals with respect to the GE Biopharma acquisition and the timing or conditionality thereof, the parties' ability to satisfy the acquisition agreement conditions and consummate the acquisition of GE Biopharma on the anticipated timetable and terms or at all, Danaher's ability to successfully integrate GE Biopharma's operations and employees with Danaher's existing business, the ability to realize anticipated financial, tax and operational synergies and benefits, GE Biopharma's performance and maintenance of important business relationships, Danaher's ability to complete the anticipated distribution of its Dental business and achieve the intended benefits thereof, deterioration of or instability in the economy, the markets served by us or GE Biopharma and the financial markets, developments and uncertainties in U.S. policy stemming from the U.S. administration, such as changes in U.S. trade and tariff policies and the reaction of other countries thereto, contractions or growth rates and cyclicality of markets we serve, competition, our ability to develop and successfully market new products and technologies and expand into new markets, the potential for improper conduct by our employees, agents or business partners, our compliance with applicable laws and regulations (including regulations relating to medical devices and the health care industry), the results of our clinical trials and perceptions thereof, our ability to effectively address cost reductions and other changes in the health care industry, our ability to successfully identify and consummate appropriate acquisitions and strategic investments and successfully complete divestitures and other dispositions, our ability to integrate the businesses we acquire and achieve the anticipated benefits of such acquisitions, contingent liabilities relating to acquisitions, investments and divestitures (including tax-related and other contingent liabilities relating to past and future IPOs, split-offs or spin-offs), security breaches or other disruptions of our information technology systems or violations of data privacy laws, the impact of our restructuring activities on our ability to grow, risks relating to potential impairment of goodwill and other intangible assets, currency exchange rates, tax audits and changes in our tax rate and income tax liabilities, changes in tax laws applicable to multinational companies, litigation and other contingent liabilities including intellectual property and environmental, health and safety matters, the rights of the United States government to use, disclose and license certain intellectual property we license if we fail to commercialize it, risks relating to product, service or software defects, product liability and recalls, risks relating to product manufacturing, the impact of our debt obligations on our operations and liquidity (including the impact of the additional debt Danaher expects to incur to finance the GE Biopharma acquisition), our relationships with and the performance of our channel partners, uncertainties relating to collaboration arrangements with third-parties, commodity costs and surcharges, our ability to adjust purchases and manufacturing capacity to reflect market conditions, reliance on sole sources of supply, the impact of deregulation on demand for our products and services, labor matters, international economic, political, legal, compliance and business factors (including the impact of the United Kingdom's decision to leave the EU and uncertainty relating to the terms and timing of such separation), disruptions relating to man-made and natural disasters and pension plan costs. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in our SEC filings, including our 2018 Annual Report on Form 10-K and Quarterly Reports on Form 10-Q for each of the first, second and third quarters of 2019. These forward-looking statements speak only as of the date of this release and except to the extent required by applicable law, the Company does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.

Statement Regarding Non-GAAP Measures

Each of the non-GAAP measures set forth above should be considered in addition to, and not as a replacement for or superior to, the comparable GAAP measure, and may not be comparable to similarly titled measures reported by other companies.  Management believes that these measures provide useful information to investors by offering additional ways of viewing Danaher Corporation's ("Danaher" or the "Company") results that, when reconciled to the corresponding GAAP measure, help our investors to:

• with respect to Adjusted Diluted Net Earnings Per Share, understand the long-term profitability trends of our business and compare our profitability to prior and future periods and to our peers; and
• with respect to core revenue and adjusted core revenue, identify underlying growth trends in our business and compare our revenue performance with prior and future periods and to our peers.

Management uses these non-GAAP measures to measure the Company's operating and financial performance, and uses core revenue and non-GAAP measures similar to Adjusted Diluted Net Earnings Per Share in the Company's executive compensation program.

The items excluded from the non-GAAP measures set forth above have been excluded for the following reasons:

• With respect to Adjusted Diluted Net Earnings Per Share:
• We exclude the amortization of acquisition-related intangible assets because the amount and timing of such charges are significantly impacted by the timing, size, number and nature of the acquisitions we consummate. While we have a history of significant acquisition activity we do not acquire businesses on a predictable cycle, and the amount of an acquisition's purchase price allocated to intangible assets and related amortization term are unique to each acquisition and can vary significantly from acquisition to acquisition. Exclusion of this amortization expense facilitates more consistent comparisons of operating results over time between our newly acquired and long-held businesses, and with both acquisitive and non-acquisitive peer companies. We believe however that it is important for investors to understand that such intangible assets contribute to revenue generation and that intangible asset amortization related to past acquisitions will recur in future periods until such intangible assets have been fully amortized.
• We exclude costs incurred pursuant to discrete restructuring plans that are fundamentally different (in terms of the size, strategic nature and planning requirements, as well as the inconsistent frequency, of such plans) from the ongoing productivity improvements that result from application of the Danaher Business System. Because these restructuring plans are incremental to the core activities that arise in the ordinary course of our business and we believe are not indicative of Danaher's ongoing operating costs in a given period, we exclude these costs from the calculation of Adjusted Diluted Net Earnings Per Share to facilitate a more consistent comparison of operating results over time.
• With respect to the other items excluded from Adjusted Diluted Net Earnings Per Share, we exclude these items because they are of a nature and/or size that occur with inconsistent frequency, occur for reasons that may be unrelated to Danaher's commercial performance during the period and/or we believe that such items may obscure underlying business trends and make comparisons of long-term performance difficult. For example, the first quarter 2019 legal contingency charges excluded from Adjusted Earnings Per Share were excluded because legal contingencies of this nature and amount are atypical for our businesses, infrequent and not representative of a trend in our underlying business.
• With respect to core revenue and adjusted core revenue, (1) we exclude the impact of currency translation because it is not under management's control, is subject to volatility and can obscure underlying business trends, and (2) we exclude the effect of acquisitions and divested product lines because the timing, size, number and nature of such transactions can vary significantly from period-to-period and between us and our peers, which we believe may obscure underlying business trends and make comparisons of long-term performance difficult. With respect to adjusted core revenue, we also exclude the impact of our Envista business as we have indicated that we intend to distribute our remaining stake in Envista, and presenting core revenue on this basis gives investors insights into Danaher's core revenue excluding Envista.

SOURCE Danaher Corporation

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=Ne36JfKuaJnlIovUVRZpT46V44D6qsPY

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 8-K filed on Oct 24, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=ZmybmRtk05ngIhnTSczQWeq0yX8NhI2Q

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Oct 24, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Oct 24, 2019, at $136.44

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=JvXY2BRu_JnyIgXkxitEKeaBGPGZJYq3

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Oct 25, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Oct 25, 2019, at $135.87

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=GmECR2yCg5mYIuZAfr1JBGBaSWE0GAdi

News Release Issued: Oct 28, 2019 (4:15pm EDT)

To view this release online and get more information about Danaher Corporation: IR Room visit: http://investors.danaher.com/2019-10-28-Danaher-To-Present-At-Baird-Global-Industrial-Conference

Danaher To Present At Baird Global Industrial Conference

WASHINGTON, Oct. 28, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Baird Global Industrial Conference in Chicago on Tuesday, November 5, 2019 at 10:30 a.m. CT. The audio will be simultaneously webcast on and the presentation will be archived on  www.danaher.com. 

About Danaher
Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher's globally diverse team of approximately 71,000 associates is united by a common culture and operating system, the Danaher Business System, and its Shared Purpose, Helping Realize Life's Potential. For more information, please visit www.danaher.com.

SOURCE Danaher Corporation

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=euCHTDA6L5lYIg79Roy-fCTM7hBqbwku

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Oct 28, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Oct 28, 2019, at $136.21

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=CPdaNaXCxJloIilt7I85LYM68zmOfLrG

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 4 filed on Oct 28, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=yK94xG2zi5mfIk5hYbKNbRLhBBBbem1Y

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 4 filed on Oct 28, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=JyHZp2V4NJkSItPc4eFaVg-ofte708TA

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 4 filed on Oct 28, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=H9V3k6ZydJmBImMa0lpPjd-nUtvfejVo

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 4 filed on Oct 28, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=yEJHRtYqnpl-IrXqU6DXiVWRkDD_rTf5

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 4 filed on Oct 28, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=EZTUjjHR5pkXIm72_2TkIOIFjlNMb9sf

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form FWP filed on Oct 30, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=btG8XDZ2FpnxInmkPTX0EtmYuvDm9qrS

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Oct 29, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Oct 29, 2019, at $137.27

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=T4EszkVKV5nuIsr2cEQ6dkt5eVwqMEHO

News Release Issued: Oct 29, 2019 (11:01pm EDT)

To view this release online and get more information about Danaher Corporation: IR Room visit: http://investors.danaher.com/2019-10-29-Danaher-Announces-Pricing-Of-Senior-Notes-Offering

Danaher Announces Pricing Of Senior Notes Offering

WASHINGTON, Oct. 29, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today that its wholly owned subsidiary, DH Europe Finance II S.à r.l. ("Danaher International II"), has priced an offering of:

• $700,000,000 principal amount of 2.050% senior notes due 2022 at an offering price of 99.994% of the principal amount;
• $700,000,000 principal amount of 2.200% senior notes due 2024 at an offering price of 99.952% of the principal amount;
• $800,000,000 principal amount of 2.600% senior notes due 2029 at an offering price of 99.903% of the principal amount;
• $900,000,000 principal amount of 3.250% senior notes due 2039 at an offering price of 99.809% of the principal amount; and
• $900,000,000 principal amount of 3.400% senior notes due 2049 at an offering price of 99.756% of the principal amount (collectively, the "senior notes").

Danaher estimates that the net proceeds from the sale of the senior notes in this offering will be approximately $3.97 billion, after deducting the underwriting discounts and estimated offering expenses payable by Danaher. Danaher anticipates using the net proceeds to fund a portion of the cash consideration payable for, and certain costs associated with, its acquisition of the Biopharma Business of GE Life Sciences (the "GE Biopharma Acquisition"). Pending completion of the GE Biopharma Acquisition, Danaher may invest the net proceeds of the offering in short-term bank deposits or invest them in interest-bearing, investment-grade securities. The senior notes will be fully and unconditionally guaranteed on a senior unsecured basis by Danaher. The offering is expected to close on November 7, 2019, subject to customary closing conditions.

The offering is being made pursuant to an effective shelf registration statement on file with the U.S. Securities and Exchange Commission.

The offering of senior notes may be made only by means of a prospectus and prospectus supplement.  A copy of the prospectus and prospectus supplement relating to the securities can be obtained by calling BofA Securities, Inc., toll-free at 1-800-294-1322, Mizuho Securities USA LLC, toll-free at 1-866-271-7403, MUFG Securities Americas Inc., toll-free at 1-877-649-6848, U.S. Bancorp Investments, Inc., toll-free at 1-877-558-2607, or Wells Fargo Securities, LLC, toll-free at 1-800-645-3751.

This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, the senior notes or any other securities, nor shall there be any offer, solicitation or sale of any security mentioned in this press release in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Danaher

Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher's globally diverse team of approximately 71,000 associates is united by a common culture and operating system, the Danaher Business System, and its Shared Purpose, Helping Realize Life's Potential.

Forward-Looking Statements

Statements in this release that are not strictly historical, including the statements regarding the offering of the senior notes, the anticipated use of proceeds and any other statements regarding events or developments that we believe or anticipate will or may occur in the future, may be "forward-looking statements" within the meaning of the federal securities laws. There are a number of important factors that could cause actual events to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking statements. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in Danaher's SEC filings, including Danaher's 2018 Annual Report on Form 10-K and Danaher's Quarterly Reports on Form 10-Q for each of the first, second and third quarters of 2019. These forward-looking statements speak only as of the date of this release and Danaher and Danaher International II do not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.

SOURCE Danaher Corporation

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=JGkCsPTZDJnvItCd_ZmzqwpidiMLNzM1

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 424B5 filed on Oct 29, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=UB7ywVuG4pnUIkUeuDzZ300k_MKZtLuw

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Oct 30, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Oct 30, 2019, at $138.25

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=w8Xgxmj9jZnXIqFlpm1SqjHhWzj8lWNx

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 8-K filed on Oct 31, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=2yfwfsThx5nuInccnRsvDiHEnYZKlhuf

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 424B5 filed on Oct 31, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=PUFPJtJnM5lBIrx3TbCQVQKa01cX-1ow

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Oct 31, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Oct 31, 2019, at $137.82

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=aCGK7AvcXpk9IkYMAEMicYiMZUznoOZF

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Nov 1, 2019 (4:10pm EDT)

Danaher Corporation (NYSE:DHR) has closed today, Nov 1, 2019, at $136.57

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=AsvhzZYhaZl4IvQohLkp2v372NAEFnc3

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Nov 4, 2019 (4:10pm EST)

Danaher Corporation (NYSE:DHR) has closed today, Nov 4, 2019, at $135.22

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=77Ay7FNR95kaIr0-oocD9DBjcvby2MGG

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Nov 5, 2019 (4:10pm EST)

Danaher Corporation (NYSE:DHR) has closed today, Nov 5, 2019, at $133.47

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=k7XKjwmcQZkFImPP2DvFPTiwgy4Cd2X2

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Nov 6, 2019 (4:10pm EST)

Danaher Corporation (NYSE:DHR) has closed today, Nov 6, 2019, at $134.86

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=KZ4t4Zwawpm5In4y4CEUopk2IvQvQ67y

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Nov 7, 2019 (4:10pm EST)

Danaher Corporation (NYSE:DHR) has closed today, Nov 7, 2019, at $134.50

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=zhJ2TcGqEZlLIskWHE03W5uw7FSIOc0z

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 8-K filed on Nov 7, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=mh42EATjbpnoIshmlpsOFjwx_T4uXXJF

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Nov 8, 2019 (4:10pm EST)

Danaher Corporation (NYSE:DHR) has closed today, Nov 8, 2019, at $135.23

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=UDv8Mq2waJmVIt5u-IiVdn9YfnQbYrvj

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Nov 11, 2019 (4:10pm EST)

Danaher Corporation (NYSE:DHR) has closed today, Nov 11, 2019, at $134.52

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=dpkcZxenwZnsIt14aJaUU_TQz0vcqpWv

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Nov 12, 2019 (4:10pm EST)

Danaher Corporation (NYSE:DHR) has closed today, Nov 12, 2019, at $135.54

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=Ef66hwkCvJllIqxV0l4VhqgZJmJCaplA

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 3 filed on Nov 13, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=dufkPRvEPpn6IoowogjJHdVp1RpLK3OY

News Release Issued: Nov 13, 2019 (4:15pm EST)

To view this release online and get more information about Danaher Corporation: IR Room visit: http://investors.danaher.com/2019-11-13-Danaher-Announces-Appointment-of-Jessica-L-Mega-MD-MPH-and-Pardis-C-Sabeti-MD-D-Phil-to-Danaher-Board

Danaher Announces Appointment of Jessica L. Mega, MD, MPH and Pardis C. Sabeti MD, D.Phil to Danaher Board

WASHINGTON, Nov. 13, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it has appointed Jessica L. Mega, MD, MPH and Pardis C. Sabeti, MD, D.Phil to its Board of Directors.

Dr. Mega is currently Chief Medical and Scientific Officer of Verily Life Sciences LLC, an Alphabet, Inc. company, where she has served since March 2015. Prior to joining Verily, she served as Cardiologist and Senior Investigator at Brigham & Women's. Dr. Mega has also served as a faculty member at Harvard Medical School and a senior investigator with the TIMI Study Group, where she helped lead international trials evaluating novel cardiovascular therapies and directed the genetics program.  

Dr. Mega is a graduate of Stanford University, Yale University School of Medicine and Harvard School of Public Health. She completed her Internal Medicine Residency at Brigham and Women's Hospital and Cardiovascular Fellowship at Massachusetts General Hospital. She is board certified in Internal Medicine and Cardiology and has won the Laennec Society, Samuel A. Levine, and Douglas P. Zipes Awards. Dr. Mega is also a Fellow of the American Heart Association (AHA) and the American College of Cardiology (ACC).

Dr. Sabeti is currently an Investigator for Howard Hughes Medical Institute, a non-profit medical research organization, where she has served since November 2015. Dr. Sabeti is a professor at both the Center for Systems Biology and the Department of Organismic and Evolutionary Biology at Harvard University and the Department of Immunology and Infectious Disease at Harvard School of Public Health. She is also a Broad Institute Member and a leader in the Broad's Infectious Disease and Microbiome Program.

Dr. Sabeti is a graduate of the Massachusetts Institute of Technology, University of Oxford (as a Rhodes Scholar) and Harvard Medical School. She is a World Economic Forum Young Global Leader and a National Geographic Emerging Explorer. In 2014, she was named a TIME magazine "Person of the Year" as one of the Ebola fighters and in 2015 as one of TIME's "100 Most Influential People." Her awards include the 2012 Smithsonian American Ingenuity Award for Natural Science, an Ellis Island Medal of Honor, and the 2017 Richard Lounsbery Award from the National Academy of Sciences.

Steven M. Rales, Chairman of the Board of Danaher Corporation, said "We are very pleased to welcome Drs. Mega and Sabeti to the Danaher Board of Directors. Their inspiring and diverse expertise in some of the most promising areas of science will provide valuable insights to Danaher as we continue to live our Shared Purpose, Helping Realize Life's Potential."

About Danaher
Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher's globally diverse team of approximately 71,000 associates is united by a common culture and operating system, the Danaher Business System, and its Shared Purpose, Helping Realize Life's Potential.

SOURCE Danaher Corporation

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=zz4nrhMggplpIurzJ6GMN4oheBhBKk7m

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Nov 13, 2019 (4:10pm EST)

Danaher Corporation (NYSE:DHR) has closed today, Nov 13, 2019, at $137.05

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=KxfNVxguxJm0Ir18-Ba3Hc3RIvisegVV

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 3 filed on Nov 13, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=va3xJjwHKZnZIg4utDgMRqOSXlZjaxN8

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 8-K filed on Nov 13, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=6UxUAjNMc5mPIhtnowvIlGgvANBnxsoJ

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Nov 14, 2019 (4:10pm EST)

Danaher Corporation (NYSE:DHR) has closed today, Nov 14, 2019, at $136.15

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=TJygnhnBb5lXInnHlFMPjSVP-njDfSYz

News Release Issued: Nov 15, 2019 (6:30am EST)

To view this release online and get more information about Danaher Corporation: IR Room visit: http://investors.danaher.com/2019-11-15-Danaher-Will-Commence-Exchange-Offer-Related-To-Divestiture-Of-Its-Remaining-Interest-In-Envista-Through-A-Split-Off

Danaher Will Commence Exchange Offer Related To Divestiture Of Its Remaining Interest In Envista Through A Split-Off

WASHINGTON, Nov. 15, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it will commence an exchange offer related to the split-off of its remaining interest in Envista Holdings Corporation (NYSE: NVST). Envista completed its initial public offering (IPO) in September 2019, with Danaher retaining an 80.6 percent ownership interest in Envista. In the exchange offer, Danaher stockholders have the option to exchange all, some or none of their shares of Danaher common stock for shares of Envista common stock owned by Danaher, subject to the terms of the offer. The exchange offer is anticipated to be tax-free for participating Danaher stockholders in the United States, except with respect to cash received in lieu of a fractional share.

Danaher also announced today that, in connection with the split-off, it has received a waiver of the 180-day lock-up with respect to the shares of Envista common stock held by it from J.P. Morgan Securities LLC, joint lead manager of the Envista IPO.

The exchange offer is designed to permit Danaher stockholders to exchange all or a portion of their shares of Danaher common stock for shares of Envista common stock at a discount of 7 percent, subject to an upper limit of 5.5784 shares of Envista common stock for each share of Danaher common stock tendered in the exchange offer. If the upper limit is not in effect, for each $100 of Danaher common stock accepted in the exchange offer, tendering stockholders would receive approximately $107.53 of Envista common stock. The per-share values of Danaher common stock and Envista common stock will be determined by reference to the simple arithmetic average of the daily volume-weighted average prices of Danaher common stock and Envista common stock on the New York Stock Exchange during the three consecutive trading days ending on and including the second trading day preceding the expiration date of the exchange offer, which would be December 9, 10 and 11, 2019, if the exchange offer is not extended or terminated.

The final exchange ratio showing the number of shares of Envista common stock that Danaher stockholders participating in the exchange offer will receive for each share of Danaher common stock accepted for exchange, including whether the upper limit is in effect, will be announced by press release no later than 5:30 p.m., New York City time, on the second trading day immediately preceding the expiration date of the exchange offer. The exchange offer will expire at 12:00 midnight, New York City time, at the end of the day on December 13, 2019, unless terminated or extended.

The final exchange ratio, when announced, and a daily indicative exchange ratio beginning on the third trading day of the exchange offer period, also will be available at http://investors.danaher.com/envista-exchange-offer.

The completion of the exchange offer is subject to certain conditions, including: at least 38.36 million shares of Envista common stock being distributed in exchange for shares of Danaher common stock validly tendered in the exchange offer; and the receipt of an opinion of counsel that the exchange offer will qualify for tax-free treatment to Danaher and its participating stockholders.

Danaher owns 127.87 million shares of Envista common stock, which represent approximately 80.6 percent of the outstanding common stock of Envista. The maximum number of shares of Danaher common stock that will be accepted in the exchange offer equals 127.87 million divided by the final exchange ratio. The exchange offer will be subject to proration if the exchange offer is oversubscribed, and the number of shares accepted in the exchange offer may be fewer than the number of shares tendered.  If the exchange offer is consummated but not fully subscribed, then the remaining shares of Envista common stock owned by Danaher will be distributed on a pro rata basis to Danaher stockholders whose shares of Danaher common stock remain outstanding after the consummation of the exchange offer.  

The exchange offer is voluntary for Danaher stockholders. No action is necessary for Danaher stockholders who choose not to participate, and their existing Danaher shares will not be impacted.

The terms and conditions of the exchange offer will be more fully described in a registration statement on Form S-4 and Form S-1 (Registration Statement), including a prospectus (Prospectus) forming a part thereof, to be filed by Envista with the U.S. Securities and Exchange Commission (SEC) today and a tender offer statement on Schedule TO (Schedule TO) to be filed by Danaher with the SEC today.

Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC will serve as dealer managers for the exchange offer.

ABOUT DANAHER

Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, Danaher's globally diverse team of approximately 71,000 associates is united by a common culture and operating system, the Danaher Business System, and its Shared Purpose, Helping Realize Life's Potential.

FORWARD-LOOKING STATEMENTS

This communication contains certain statements about Danaher and Envista that are forward-looking statements. Forward-looking statements are based on current expectations and assumptions regarding Danaher's and Envista's respective businesses, the economy and other future conditions. In addition, the forward-looking statements contained in this communication may include statements about the expected effects on Danaher and Envista of the exchange offer, the anticipated timing and benefits of the exchange offer, Danaher's and Envista's anticipated financial results, and all other statements in this communication that are not historical facts.

Because forward-looking statements relate to the future, by their nature, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and are detailed more fully in Danaher's and Envista's respective periodic reports filed from time to time with the SEC, the Registration Statement, including the Prospectus forming a part thereof, the Schedule TO and other exchange offer documents filed by Envista or Danaher, as applicable, with the SEC. Such uncertainties, risks and changes in circumstances could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Forward-looking statements included herein are made as of the date hereof, and neither Danaher nor Envista undertakes any obligation to update publicly such statements to reflect subsequent events or circumstances, except to the extent required by applicable securities laws. Investors should not put undue reliance on forward-looking statements.

ADDITIONAL INFORMATION

This communication is for informational purposes only and is neither an offer to sell or the solicitation of an offer to buy any securities nor a recommendation as to whether investors should participate in the exchange offer. The offer will be made solely by the Prospectus. The Prospectus will contain important information about the exchange offer, Danaher, Envista, and related matters, and Danaher will deliver the Prospectus to holders of Danaher common stock. Investors and security holders are urged to read the Prospectus and any other relevant documents filed with the SEC, when they become available and before making any investment decision, because they contain important information about Danaher, Envista and the exchange offer.  None of Danaher, Envista, or any of their respective directors or officers makes any recommendation as to whether investors should participate in the exchange offer.

Envista will file with the SEC the Registration Statement, including the Prospectus forming a part thereof, and Danaher will file with the SEC the Schedule TO, which will contain important information about the exchange offer.  Holders of Danaher common stock may obtain copies of the Prospectus, the Registration Statement, the Schedule TO, other related documents, and any other information that Danaher and Envista file electronically with the SEC free of charge at the SEC's website at www.sec.gov.

SOURCE Danaher Corporation

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=hm7fx4vwJplXIqPiO04vQ_5xPpOuK0Y3

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 425 filed on Nov 15, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=tqMuDZXJ25nwIsQouqNoIgP4i2FNu7Nm

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form SC TO-I filed on Nov 15, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=bvkA7wRu9pmeIlWFgdyVRU1t5EXnTULw

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 425 filed on Nov 15, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=U7cfwZGC6ZlzImW3-UfyZpX3uUGNj7gW

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Nov 15, 2019 (4:10pm EST)

Danaher Corporation (NYSE:DHR) has closed today, Nov 15, 2019, at $142.99

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=rPc6v26KSZlCIskiADMcNAUv322U-dWt

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 425 filed on Nov 15, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=je4bRnEzR5n0Isyd5ZI3IoRbFQFh595P

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 4 filed on Nov 15, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=DnZ2T8G2OZkzImn3v0orSdymSupibPxV

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 425 filed on Nov 15, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=ugEVUqtFaJlNIoajAeQ9Rwlf6JY7O2IH

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 425 filed on Nov 15, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=wsAMphJJppnDIgA-5oxudV7DvyKCwJhp

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 425 filed on Nov 15, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=pUbC67jgP5mzIqN9Vxq_-lSffPP4hdJ-

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 425 filed on Nov 18, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=8hCtcYZTBpm2Iiwv0Z2ImZbaj_Xtl24a

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 425 filed on Nov 18, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=WAAxugvPOpmVIscT78xvCiJv-2CNUkDO

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 425 filed on Nov 18, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=VAFXZKTvUJkMIui_575_VDXrqsYXqCnr

Daily Closing Price for Danaher Corporation (NYSE:DHR) - Nov 18, 2019 (4:10pm EST)

Danaher Corporation (NYSE:DHR) has closed today, Nov 18, 2019, at $140.23

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=vqPZg2WkFJnNIryzSbegoZGGj0BVgV39

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 425 filed on Nov 18, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=W3AZfEdaXJlkIlVZPIpNr32McuJRcwpa

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.

SEC Form 4 filed on Nov 18, 2019

View all SEC filings for Danaher Corporation (NYSE:DHR)

Get more information about Danaher Corporation (NYSE:DHR)

To unsubscribe or change your settings click here:
http://investors.danaher.com/index.php?s=subscribe&code=TtwFYCrmv5lNIs1jBN7a6oOlECQZJkln

Danaher Corporation (NYSE:DHR) SEC Filing Alert

The following document for Danaher Corporation (NYSE:DHR) was filed with the U.S. Securities and Exchange Commission.